Marijuana, the Endocannabinoid System and the Female Reproductive System

Por Brents, Lisa K.
Publicado no Yale J Biol Med (2016)

The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products

Por Brents, Lisa K., Prather, Paul L.
Publicado em 2013

Automated Quantification of Opioid Withdrawal in Neonatal Rat Pups Using Ethovision® XT Software

Por Kulbeth, Hanna J., Fukuda, Saki, Brents, Lisa K.
Publicado no Neurotoxicol Teratol (2021)

Personality variables modify the relationship between childhood maltreatment history and poor functional outcomes

Por Brents, Lisa K., James, G. Andrew, Cisler, Joshua M., Kilts, Clinton D.
Publicado no Psychiatry Res (2018)

Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs

Por Safe, Stephen H., Prather, Paul L., Brents, Lisa K., Chadalapaka, Gayathri, Jutooru, Indira
Publicado em 2012

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

Por Rajasekaran, Maheswari, Brents, Lisa K., Franks, Lirit N., Moran, Jeffery H., Prather, Paul L.
Publicado em 2013

The role of childhood maltreatment in the altered trait and global expression of personality in cocaine addiction

Por Brents, Lisa K, Tripathi, Shanti Prakash, Young, Jonathan, James, G Andrew, Kilts, Clinton D
Publicado no J Psychiatr Res (2015)

Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy

Por Brents, Lisa K., Zimmerman, Sarah M., Saffell, Amanda R., Prather, Paul L., Fantegrossi, William E.
Publicado em 2013

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

Por Brents, Lisa K., Reichard, Emily E., Zimmerman, Sarah M., Moran, Jeffery H., Fantegrossi, William E., Prather, Paul L.
Publicado em 2011

Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors

Por Madadi, Nikhil Reddy, Penthala, Narsimha Reddy, Brents, Lisa K., Ford, Benjamin M., Prather, Paul L., Crooks, Peter A
Publicado em 2013

AM-251 and Rimonabant Act as Direct Antagonists at Mu-Opioid Receptors: Implications for Opioid/Cannabinoid Interaction Studies

Por Seely, Kathryn A., Brents, Lisa K., Franks, Lirit N., Rajasekaran, Maheswari, Zimmerman, Sarah M., Fantegrossi, William E., Prather, Paul L.
Publicado em 2012

A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors

Por Seely, Kathryn A., Brents, Lisa K., Radominska-Pandya, Anna, Endres, Gregory W., Keyes, Gregory S., Moran, Jeffery H., Prather, Paul L.
Publicado em 2012

Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer

Por Liu, Xinyi, Jutooru, Indira, Lei, Ping, Kim, KyoungHyun, Lee, Syng-ook, Brents, Lisa K., Prather, Paul L., Safe, Stephen
Publicado no Mol Cancer Ther (2012)

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial ag...

Por Brents, Lisa K., Gallus-Zawada, Anna, Radominska-Pandya, Anna, Vasiljevik, Tamara, Prisinzano, Thomas E., Fantegrossi, William E., Moran, Jeffery H., Prather, Paul L.
Publicado em 2012

Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors

Por Brents, Lisa K., Medina-Bolivar, Fabricio, Seely, Kathryn A., Nair, Vipin, Bratton, Stacie M., Ñopo-Olazabal, Luis, Patel, Ronak Y., Liu, Haining, Doerksen, Robert J., Prather, Paul L., Radominska-Pandya, Anna
Publicado em 2011

Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

Por Chimalakonda, Krishna C., Seely, Kathryn A., Bratton, Stacie M., Brents, Lisa K., Moran, Cindy L., Endres, Gregory W., James, Laura P., Hollenberg, Paul F., Prather, Paul L., Radominska-Pandya, Anna, Moran, Jeffery H.
Publicado em 2012

In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome

Por Griffin, Bryce A., Caperton, Caitlin O., Russell, Lauren N., Cabanlong, Christian V., Wilson, Catheryn D., Urquhart, Kyle R., Martins, Bradford S., Zita, Marcelle Dina, Patton, Amy L., Alund, Alexander W., Owens, S. Michael, Fantegrossi, William E., Moran, Jeffery H., Brents, Lisa K.
Publicado no J Pharmacol Exp Ther (2019)